In July 2026, a federal judge in Michigan sentenced Brandon Piper after prosecutors reported he sold imported peptides, semaglutide, and tirzepatide through websites that marketed the products for research purposes only.

Federal Sentencing Follows Online Sales of Imported Peptides and GLP-1 Drugs

On July 23, 2026, the U.S. Attorney’s Office for the Western District of Michigan reported that Brandon Piper, 35, of Gobles, Michigan, was sentenced to 21 months in federal prison for conspiring to introduce misbranded drugs into the market. The case involved imported peptides, semaglutide, and tirzepatide from China, sold through websites that described the products as intended for research use only. For Med Spa and wellness operators that offer peptides, GLP-1 medications, or similar products, the case involves drug sourcing, prescription requirements, and labeling.

Read more at: https://www.spakinect.com/news/michigan-federal-peptide-glp1-drug-sentencing